FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Phase III | FDA | Phase II | Drug Trials | Isolagen

SPOTLIGHT: Isolagen modifies trial in response to FDA

Tools


In order to clarify protocol issues and questions raised by the FDA, Isolagen says it will modify its ongoing late-stage trial of Isolagen Therapy for acne scars and make it a Phase II/III trial. Release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Drug Trials   Isolagen   Phase III   FDA   Phase II  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.